These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33166691)

  • 1. Temocillin susceptibility in Enterobacterales with an ESBL/AmpC phenotype.
    Kresken M; Pfeifer Y; Werner G
    Int J Antimicrob Agents; 2021 Jan; 57(1):106223. PubMed ID: 33166691
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England.
    Livermore DM; Hope R; Fagan EJ; Warner M; Woodford N; Potz N
    J Antimicrob Chemother; 2006 May; 57(5):1012-4. PubMed ID: 16531428
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods.
    Teethaisong Y; Eumkeb G; Chumnarnsilpa S; Autarkool N; Hobson J; Nakouti I; Hobbs G; Evans K
    J Med Microbiol; 2016 Oct; 65(10):1079-1087. PubMed ID: 27481506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units.
    Glupczynski Y; Huang TD; Berhin C; Claeys G; Delmée M; Ide L; Ieven G; Pierard D; Rodriguez-Villalobos H; Struelens M; Vaneldere J
    Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):777-83. PubMed ID: 17668253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae.
    Balakrishnan I; Awad-El-Kariem FM; Aali A; Kumari P; Mulla R; Tan B; Brudney D; Ladenheim D; Ghazy A; Khan I; Virgincar N; Iyer S; Carryn S; Van de Velde S
    J Antimicrob Chemother; 2011 Nov; 66(11):2628-31. PubMed ID: 21810837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France.
    Farfour E; Si Larbi AG; Cattoir V; Corvec S; Guillard T; Grillon A; Isnard C; Mérens A; Degand N; Billard-Pomares T; Fournier D; Bille E; Le Brun C; Plouzeau C; Flevin E; Yin N; Woerther PL; Lourtet J; Lesprit P; Le Monnier A;
    Diagn Microbiol Infect Dis; 2021 Jul; 100(3):115368. PubMed ID: 33813355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The implications of endemic IMP-4 carbapenemase for clinical laboratory susceptibility testing.
    Goire N; Harnett GB; O'Reilly LC; Ingram PR; Leung MJ; Speers DJ; Healy PE; Inglis TJ
    J Microbiol Methods; 2016 May; 124():10-2. PubMed ID: 26945518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland.
    Kuch A; Zieniuk B; Żabicka D; Van de Velde S; Literacka E; Skoczyńska A; Hryniewicz W
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1185-1191. PubMed ID: 32096107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new rapid method for detecting extended-spectrum beta-lactamase/AmpC-producing Enterobacteriaceae directly from positive blood cultures using the Uro4 HB&L™ system.
    Athamna A; Freimann S
    Braz J Microbiol; 2019 Oct; 50(4):927-933. PubMed ID: 31209794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging problems with plasmid-mediated DHA and CMY AmpC beta-lactamases in Enterobacteriaceae in Singapore.
    Koh TH; Sng LH; Wang G; Hsu LY; Lin RT; Tee NW
    Int J Antimicrob Agents; 2007 Sep; 30(3):278-80. PubMed ID: 17587551
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of ESBL- and AmpC-positive Enterobacteriaceae at the Department of Neonatology, University Hospital Olomouc.
    Husičková V; Chromá M; Kolář M; Hricová K; Stosová T; Kantor L; Dubrava L
    Curr Microbiol; 2011 Jun; 62(6):1664-70. PubMed ID: 21400083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary tract isolates of Enterobacteriaceae from hospitalized patients in the Arkhangelsk region, Russia: antimicrobial susceptibility and characterization of extended-spectrum beta-lactamases strains.
    Vorobieva V; Naseer U; Bazhukova T; Semenova N; Haldorsen BC; Aasnaes B; Simonsen GS; Sundsfjord A
    Scand J Infect Dis; 2010 Oct; 42(10):797-800. PubMed ID: 20438286
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe.
    Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y;
    Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Molecular and Phenotypic Antimicrobial Susceptibility Testing Is Beneficial in Detection of ESBL and AmpC Beta-Lactamase Producing Isolates of Enterobacteriaceae in Pediatric Patients with Bloodstream Infections.
    Powell EA; Khalil N; DeBurger B; Mortensen JE
    Microb Drug Resist; 2020 Jul; 26(7):825-830. PubMed ID: 32181692
    [No Abstract]   [Full Text] [Related]  

  • 16. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
    Hartl R; Widhalm S; Kerschner H; Apfalter P
    Clin Microbiol Infect; 2013 May; 19(5):E230-2. PubMed ID: 23397897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
    Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
    J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterization of TEM-type ESBL-associated antibacterial resistance in Enterobacteriaceae in a tertiary hospital in Ghana.
    Oduro-Mensah D; Obeng-Nkrumah N; Bonney EY; Oduro-Mensah E; Twum-Danso K; Osei YD; Sackey ST
    Ann Clin Microbiol Antimicrob; 2016 May; 15():29. PubMed ID: 27145868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Flow Cytometry Test for Identification of Different Carbapenemases in Enterobacteriaceae.
    Silva AP; Faria-Ramos I; Ricardo E; Miranda IM; Espinar MJ; Costa-de-Oliveira S; Cantón R; Rodrigues AG; Pina-Vaz C
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3824-6. PubMed ID: 27021318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibilities of clinical isolates of carbapenemase-producing Enterobacteriaceae to fosfomycin and tigecycline.
    Choudhury S; Yeng JL; Krishnan PU
    Clin Microbiol Infect; 2015 Oct; 21(10):e75-6. PubMed ID: 26086572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.